» Articles » PMID: 30343897

Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 2018 Oct 23
PMID 30343897
Citations 75
Affiliations
Soon will be listed here.
Abstract

Multiple sclerosis is a complex neurological disease, with ∼20% of risk heritability attributable to common genetic variants, including >230 identified by genome-wide association studies. Multiple strands of evidence suggest that much of the remaining heritability is also due to additive effects of common variants rather than epistasis between these variants or mutations exclusive to individual families. Here, we show in 68,379 cases and controls that up to 5% of this heritability is explained by low-frequency variation in gene coding sequence. We identify four novel genes driving MS risk independently of common-variant signals, highlighting key pathogenic roles for regulatory T cell homeostasis and regulation, IFNγ biology, and NFκB signaling. As low-frequency variants do not show substantial linkage disequilibrium with other variants, and as coding variants are more interpretable and experimentally tractable than non-coding variation, our discoveries constitute a rich resource for dissecting the pathobiology of MS.

Citing Articles

Linking Pathogenesis to Fall Risk in Multiple Sclerosis.

Patel J, Fraix M, Agrawal D Arch Intern Med Res. 2025; 8(1):36-47.

PMID: 40041760 PMC: 11879276. DOI: 10.26502/aimr.0194.


Genes, Gene Loci, and Their Impacts on the Immune System in the Development of Multiple Sclerosis: A Systematic Review.

Arneth B Int J Mol Sci. 2024; 25(23).

PMID: 39684620 PMC: 11641802. DOI: 10.3390/ijms252312906.


Association between 25(OH) vitamin D and multiple sclerosis: cohort, shared genetics, and Causality.

Yu X, Lu H, Li J, Su M, Li X, Jin Y Nutr J. 2024; 23(1):151.

PMID: 39616386 PMC: 11608472. DOI: 10.1186/s12937-024-01059-4.


Computational Analysis of S1PR1 SNPs Reveals Drug Binding Modes Relevant to Multiple Sclerosis Treatment.

Kores K, Lesnik S, Bren U Pharmaceutics. 2024; 16(11).

PMID: 39598537 PMC: 11597183. DOI: 10.3390/pharmaceutics16111413.


MicroRNAs targeting TGF-β signaling exacerbate central nervous system autoimmunity by disrupting regulatory T cell development and function.

Rau C, Severin M, Lee P, Deffenbaugh J, Liu Y, Murphy S Eur J Immunol. 2024; 54(6):e2350548.

PMID: 38634287 PMC: 11156541. DOI: 10.1002/eji.202350548.


References
1.
Sadler A, Williams B . Interferon-inducible antiviral effectors. Nat Rev Immunol. 2008; 8(7):559-68. PMC: 2522268. DOI: 10.1038/nri2314. View

2.
Marouli E, Graff M, Medina-Gomez C, Lo K, Wood A, Kjaer T . Rare and low-frequency coding variants alter human adult height. Nature. 2017; 542(7640):186-190. PMC: 5302847. DOI: 10.1038/nature21039. View

3.
Beecham A, Patsopoulos N, Xifara D, Davis M, Kemppinen A, Cotsapas C . Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet. 2013; 45(11):1353-60. PMC: 3832895. DOI: 10.1038/ng.2770. View

4.
Dankowski T, Buck D, Andlauer T, Antony G, Bayas A, Bechmann L . Successful Replication of GWAS Hits for Multiple Sclerosis in 10,000 Germans Using the Exome Array. Genet Epidemiol. 2015; 39(8):601-8. DOI: 10.1002/gepi.21933. View

5.
Jakkula E, Leppa V, Sulonen A, Varilo T, Kallio S, Kemppinen A . Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. Am J Hum Genet. 2010; 86(2):285-91. PMC: 2820168. DOI: 10.1016/j.ajhg.2010.01.017. View